Navigation

Contact Us

 

Elmer Press Inc.
9225 Leslie Street, Suite 201
Richmond Hill
Ontario, L4B 3H6
Canada

Tel:  647-671-2629
Fax: 647-498-1289

English Editing Service

English editing for manuscripts from non-native English speakers. More...

      editing

Special Issue

 

Topic: Nutrition/Diet for HDL (call for submissions)
HDL is a lipoprotein which has anti-atherogenic property by reversing cholesterol transport from the peripheral tissues to liver. More...

Advertising

ad
Our journals are open access, which means all the contents of the journals are accessible freely to all viewers from every part of the world as long as they have internet accessibility, More...

Collaboration

Elmer Press publishes open access journals in clinical medicine fields, we are glad to collaborate with medical professional societies, institutions, academic organizations and bodies, to promote medical research and healthcare. Please contact production"at"elmerpress.com for details.

Journals Indexed in PubMed

Elmer Press publishes open access journals in various clinical medicine disciplines, currently we have the following journals fully indexed in PubMed and PubMed Central. Indexed by PubMed denotes the wide accessible and searchable of published articles to world researchers. Gastroenterology Research; Cardiology Research; Journal of Clinical Medicine Research; World Journal of Oncology.

Journals Indexed in Web of Science-ESCI


Emerging Sources Citation Index (ESCI) is a new index in the Web of Science™ Core Collection, Elmer Press has 3 journals indexed by ESCI, including Gastroenterology Research, Cardiology Research, and Journal of Endocrinology and Metabolism. For more details about ESCI, please click here.

Journals Permanent Archiving

All journals published by Elmer Press are archived in Portico, which provides permanent digital archiving for scholarly journals.

For Librarians

librarian

 

All journals published by Elmer Press Inc are fully open access, fulltexts of all articles can be viewed online for free immediately after publishing. For print journal subscription, please contact us. More...

Latest Articles

Long-Term Effects of Ipragliflozin on Diabetic Nephropathy and Blood Pressure in Patients With Type 2 Diabetes: 104-Week Follow-up of an Open-Label Study
by Jeevan Nagendran et al.
Journal of Clinical Medicine Research, 2018; Aug, 10(9):679-687.
In our previous study, we investigated the efficacy of ipragliflozin, a sodium-glucose cotransporter (SGLT) 2 inhibitor on diabetic nephropathy in patients with type 2 diabetes and demonstrated that ipragliflozin significantly improved diabetic nephropathy in addition to reducing HbA1c and body weight. Herein, we conducted post-trial monitoring to determine whether these lowering effects on blood glucose and body weight or the beneficial effects on diabetic nephropathy were maintained long-term (104 weeks) after starting ipragliflozin treatment.

 Open Access

The Characteristics and Trends in Adrenocortical Carcinoma: A United States Population Based Study

by Eliza Sharma et al.
Journal of Clinical Medicine Research, 2018; May, 10(8):636-640.
Adrenocortical carcinoma (ACC) is a rare malignancy with poor prognosis. Data on the incidence of ACC, however, are scarce and not recent. The purpose of this study was to characterize the tumor and the patients developing ACC over the last four decades using a large population based database. We identified all cases of ACC diagnosed between 1973 - 2014 from the Surveillance, Epidemiology, and End Results-18 registry.

 Open Access

Internists’ Perceptions of Proton Pump Inhibitor Adverse Effects and Impact on Prescribing Practices: Results of a Nationwide Survey

by Jacob E. Kurlander, Mark Kolbe, Joel H. Rubenstein, Caroline R. Richardson, Michele Heisler, Arlene Weissman, Raymond De Vries, Sameer D. Saini
Gastroenterology Research, 2018;11(1):11-17.
Observational studies have linked proton pump inhibitors (PPIs) with serious adverse effects. The study aimed to evaluate internists’ perceptions of PPI harms and effects on prescribing.

 Open Access